Past Issue
Vol. 6, No. 4
Jul–Aug 2000
|
|
|
Dispatch
Antimicrobial Resistance in Salmonella Enteritidis, Southern Italy, 1990-1998
Antonino Nastasi,* Caterina Mammina,† and Lucia Cannova†
*University of Florence, Florence, Italy; and †University of Palermo, Palermo,
Italy
During 1990 to 1998, we identified
multidrug-resistant isolates of Salmonella Enteritidis in southern Italy. Plasmids containing class I integrons and
codifying for synthesis of extended-spectrum ß-lactamases were detected. Active surveillance for resistance to antimicrobial agents is needed to guard
against the possible spread of resistant clones. |
In the last decade, the incidence of Salmonella Enteritidis infections has increased in many countries. In Europe, this serotype now predominates among
Salmonella isolates from humans (1). In southern Italy, identification of S. Enteritidis has increased steadily since 1990, in parallel with increases
throughout Europe. After a temporary decline in 1995 and 1996, isolation rates from both sporadic cases and foodborne outbreaks increased. During
1998, records from the Center for Enteric Pathogens in southern Italy show identification rates of approximately 45% in all human Salmonella isolates
and 61% in isolates from patients hospitalized for enteritis. In the Enteritidis serotype, resistance to antimicrobial drugs is rare, but resistance to
antibacterial agents has been increasing in some Mediterranean countries (2).
We conducted a retrospective study of antimicrobial drug resistance patterns of
S. Enteritidis isolates identified from human, animal, and environmental
sources in southern Italy from 1990 to 1998. We also investigated mechanisms of resistance at the molecular level.
The Study
From 1990 to 1998, 1,889 strains of S. Enteritidis were referred to the Center for Enteric Pathogens, Palermo, southern Italy: 86% were of human origin,
2.9% from infected animals (mainly poultry), 6.7% from sewage plant effluents and surface water, and 4.4% from foods (mainly eggs and egg-based
dishes). All strains were biochemically identified by standard tests and were serotyped for somatic and flagellar antigen identification. Phage types were
determined with 10 typing phages (3).
Forty-four (2.3%) of the 1,889 strains tested were resistant to at least one antibiotic; we examined patterns of antibiotic resistance, phage types, and
plasmid profiles of these 44 strains (Table). Resistance to
ampicillin, alone or associated with other ß-lactams, and tetracycline, alone or associated with
aminoglycosides, sulfonamides, and trimethoprim, were the most commonly encountered phenotypes among the
S. Enteritidis isolates studied. Of the 17
tetracycline-resistant strains, nine and eight, respectively, had transferrable plasmids of 80 and 30
MDal.
Table. Resistance patterns
of Salmonella Enteriditis strains, southern Italy, 1990–1998 |
|
|
|
|
|
|
|
Resistance |
|
|
|
|
|
|
Plasmid |
pattern of |
Integrons |
|
|
|
|
|
pattern |
recipient |
(size of |
|
|
|
Phage |
Resistance |
(mol. wt., |
Escherichia |
inserted |
Year |
Source |
Region |
types |
patterna |
MDa) |
coli |
regions, kb) |
|
1990 |
human |
Sicily |
RDNC |
Ap |
36, 25 |
|
|
1991 |
cakeb |
Sicily |
4 |
Su, Tp, Tc |
80,c 36 |
Tp, Tc |
2.5 |
1992 |
seafood |
Apulia |
4 |
Ap |
30 |
Ap |
|
1992 |
seafood |
Apulia |
4 |
Ap |
36, 30 |
Ap |
|
1992 |
human |
Sicily |
4 |
Ap, Kf, Atm, Caz, Cro, Ctx, Su |
30 |
|
|
1992 |
dog |
Sicily |
RDNC |
Ap, Kf, Sm, Su, Tc |
30 |
Ap, Sm, Su, Tc |
|
1992 |
human |
Calabria |
4 |
Gm, Sm, Su |
80, 70 |
|
0.8 |
1992 |
human |
Sicily |
RDNC |
Sm, Su, Tp |
80, 36 |
Sm, Su, Tp |
|
1992 |
human |
Calabria |
1 |
Su, Tp, Tc |
80, 36 |
Tp, Tc |
1.5 |
1993 |
human |
Calabria |
7 |
Gm, Sm, Tc |
80 |
Tc |
|
1993 |
human |
Sicily |
4 |
Sm, Tc |
80, 36 |
Tc |
|
1993 |
human |
Sicily |
4 |
Sm, Su, Tp, Tc |
80, 36 |
Sm, Su, Tp, Tc |
|
1993 |
human |
Sicily |
7 |
Sm, Su, Tp, Tc |
80, 36 |
Sm, Su, Tp, Tc |
|
1994 |
human |
Sicily |
4 |
Ap, Kf, Atm, Caz, Cro, Ctx, Su |
80, 36 |
Ap, Kf, Atm, Caz, Cro, Ctx |
2.0 |
1994 |
human |
Sicily |
RDNC |
Tc |
36, 30 |
Tc |
|
1994 |
human |
Sicily |
4 |
Tc |
36, 30 |
Tc |
|
1995 |
human |
Calabria |
4 |
Tc |
36, 30 |
Tc |
|
1995 |
human |
Apulia |
4 |
Tc |
80, 36 |
Tc |
|
1995 |
human |
Apulia |
7 |
Tc |
36, 30 |
Tc |
|
1996 |
human |
Sicily |
4 |
Ap, Kf, Atm, Caz, Cro, Ctx, Su |
80, 36 |
Ap, Kf, Atm, Caz, Cro, Ctx |
2.0 |
1996 |
humanb |
Sicily |
RDNC |
Tc |
36, 30 |
Tc |
|
1996 |
human |
Apulia |
RDNC |
Tc |
30 |
Tc |
|
1997 |
human |
Sicily |
4 |
Ap |
36, 30 |
|
|
1997 |
human |
Sicily |
4 |
Ap |
36 |
|
|
1997 |
human |
Sicily |
1 |
Ap |
36, 30 |
|
|
1997 |
human |
Calabria |
4 |
Ap, Kf, Atm, Caz, Cro, Ctx, Cm, Su |
70, 36 |
Ap, Kf, Atm, Caz, Cro, Ctx, Cm |
|
1997 |
human |
Calabria |
4 |
Ap, Kf, Atm, Caz, Cro, Ctx, Cm, Su |
38, 36 |
Ap, Kf, Atm, Caz, Cro, Ctx, Cm |
|
1997 |
human |
Calabria |
RDNC |
Ap, Kf, Atm, Caz, Cro, Ctx, Cm, Su |
80, 36 |
Ap, Kf, Atm, Caz, Cro, Ctx |
2.0 |
1997 |
human |
Apulia |
1 |
Ap, Sm, Tc |
36, 30 |
Ap, Sm, Tc |
|
1997 |
human |
Calabria |
1 |
Ap, Sm, Tc |
36, 32 |
Ap, Sm, Tc |
|
1997 |
human |
Sicily |
4 |
Cm, Su, Tp |
36, 32 |
Cm, Su, Tp |
|
1997 |
human |
Sicily |
4 |
Su, Tp |
36 |
|
|
1997 |
poultry |
Sicily |
14b |
Tc |
80, 36 |
Tc |
|
1997 |
human |
Sicily |
14b |
Tc |
80 |
Tc |
|
1997 |
human |
Sicily |
NT |
Tc |
80 |
Tc |
|
1997 |
human |
Sicily |
13 |
Tc |
80, 36 |
Tc |
|
1997 |
human |
Sicily |
RDNC |
Tc, Nal |
80, 36 |
Tc |
|
1998 |
human |
Sicily |
4 |
Ap |
70, 36 |
Ap |
|
1998 |
sewage |
Sicily |
RDNC |
Ap, Kf |
36 |
|
|
1998 |
human |
Sicily |
RDNC |
Tc |
36, 30 |
Tc |
|
1998 |
human |
Sicily |
7 |
Tc |
30 |
Tc |
|
1998 |
human |
Sicily |
6a |
Tc |
80, 36 |
Tc |
|
1998 |
human |
Sicily |
RDNC |
Tc |
36, 30 |
Tc |
|
1998 |
poultry |
Sicily |
RDNC |
Tc |
30 |
Tc |
|
|
Ap, ampicillin; Kf, cephalotin; Atm, aztreonam; Caz,
ceftazidime; Cro, ceftriaxone; Ctx, cefotaxime; Cm, chloramphenicol; Gm,
gentamicin; Sm, streptomycin; Su, sulfonamides; Tp, trimethoprim; Tc,
tetracycline; Nal, nalidixic acid; RDNC, reaction did not conform; NT,
not typable.
aThe strains were screened for resistance to ampicillin (10 µg),
cephalotin (30 µg), cefotaxime (30 µg), chloramphenicol (30 µg),
ciprofloxacin (5 µg), gentamicin (10 µg), nalidixic acid (30 µg),
streptomycin (10 µg), sulfonamides (300 µg), tetracycline (30 µg),
and trimethoprim (5 µg). Strains resistant to cefotaxime were
subsequently tested for susceptibility to aztreonam (30 µg),
ceftazidime (30 µg), and ceftriaxone (30 µg). Resistance was
determined by disk diffusion (4). The double-disk
synergy test was performed (4) on strains presumed to
produce extended-spectrum ß-lactamase (ESBL). Plasmid DNA was extracted
by an alkaline lysis method (5). Electrophoresis on
0.7% agarose gels was performed on samples of plasmid DNA. The
approximate molecular weight of plasmids was estimated by comparison
with plasmids of known molecular size extracted from Escherichia coli.
Conjugation experiments were carried out in Luria-Bertani broth.
Transconjugant colonies of E. coli were selected after growth on
MacConkey agar containing rifampin (300 µg/ml) and ampicillin (50
µg/ml), streptomycin (30 µg/ml), chloramphenicol (30 µg/ml), or
tetracycline (30 µg/ml). All resistant isolates were screened for class
I integrons by a strict protocol with oligonucleotide primers specific
for the sequence of the 5'-CS and 3'-CS regions adjacent to the
site-specific recombinational insertion sequence (6).
Primer sequences were 5'-CS, GGCATCCAAGCAGCAAG and 3'-CS,A
AGCAGACTTGACCTGA (5).
bSource in outbreak.
cNumbers in bold indicate the approximate molecular
size of resistance plasmids. |
Six strains isolated from pediatric patients with enteritis (three in 1992, 1994, and 1996 in Sicily and three in 1997 in Calabria) were resistant to
ampicillin, aztreonam, cephalotin, third-generation cephalosporins, and sulfonamides by the Kirby-Bauer method
(7). Two of the 1997 isolates were also
resistant to chloramphenicol. The double-disk synergy test was positive for all six isolates, suggesting the production of ESBL. In five cases, plasmids of
38, 70, and 80 MDal were shown by conjugation to mediate the complete pattern of resistance. In one strain identified in 1992, a 30-MDal plasmid was
detected, but the resistance traits could not be transferred to recipient cells.
Six isolates of S. Enteritidis carried integrons with inserted regions of DNA of 0.8 to 2.5
kb (Table). Transconjugant Escherichia coli from these strains
was also positive, indicating that the integrons were carried on plasmids. DNA fragments of approximately 2.0
kb were obtained from ESBL-producing
strains.
Conclusions
During the 9-year study, a small proportion of resistant strains was found within Enteritidis, 2.3% showing resistance to at least one antimicrobial drug
and 0.9% to three or more. Prevalence in southern Italy was similar to that in other European countries, such as England and Wales
(8) and the Czech
Republic (9); however, it was lower than prevalence detected from 1987 to 1993 in Greece, where up to 67.4% of strains of
S. Enteritidis from human
and nonhuman sources were resistant to antibiotics and the resistance rate increased steadily until 1991
(2). No temporal trend or possible association
with source was investigated in resistance patterns identified in southern Italy because resistant strains are rare and usually from human sources.
The unusual characteristics of antimicrobial resistance of some S. Enteritidis isolates highlight the problem of emergence of drug resistance in a common
serotype of Salmonella, transmitted in popular food items and often implicated in foodborne outbreaks. We identified six ESBL-producing isolates from
epidemiologically unrelated cases, a rare finding (10-12). All six strains were isolated from community-acquired enteritis cases in otherwise healthy
children, who had no recent history of hospitalization or antimicrobial therapy. This observation is not consistent with the hypothesis that
multidrug-resistant clones are selected or resistance determinants are acquired as a consequence of antibiotic treatment. Moreover, the presence of
integrons in strains isolated as long ago as 1991 is of particular concern because of the ability of these elements to disseminate resistance traits by intra-
and inter-specific gene transfer (13,14).
Although most isolates identified in southern Italy were susceptible, some aspects of the epidemiology of
S. Enteritidis are cause for concern. Active
monitoring of S. Enteritidis strains for resistance to antibacterial drugs seems crucial because of the public health implications of a potential spread of
resistant clones.
Acknowledgments
Dr. Mammina is a physician in the Department of Hygiene and Microbiology "G. D'Alessandro" of the University of Palermo. Her research interests
focus on the molecular epidemiology of bacterial diseases, with an emphasis on enteric pathogens and tuberculosis.
Address for correspondence: Caterina Mammina, Via del Vespro 133, I-90127 Palermo, Italy; fax: 39-091-655-3641; e-mail:
diptigmi@mbox.unipa.it
References
- Fisher J. Salm/Enter-Net records a resurgence in Salmonella enteritidis infection through the European Union. Eurosurveillance Weekly 1997;1:June
26.
- Tassios PT, Markogiannakis A, Vatopoulos AC, Katsanikou E, Velonakis EN, Kourea-Kremastinou J, et al.
Molecular epidemiology of antibiotic
resistance of Salmonella enteritidis during a 7-year period in Greece. J Clin Microbiol
1997;35:1316-21.
- Ward LR, De Sa JDH, Rowe B. A phage-typing scheme for
Salmonella enteritidis. Epidemiol Infect 1987;99:291-4.
- National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests for bacteria that grow
aerobically. Approved standard M7-A4. Villanova (PA): The Committee; 1997.
- Birnboim HC, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA.
Nucleic Acids Res 1979;7:1513-23.
- Lévesque C, Piché L, Larose C, Roy PH. PCR mapping of integrons reveals several novel combinations of resistance genes.
Antimicrob Agents
Chemother 1995;39:185-1.
- Bauer AW, Kirby MMW, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol
1966;45:493-6.
- Threlfall EJ, Ward LR, Skinner JA, Rowe B. Increase in multiple antibiotic resistance in nontyphoidal salmonellas from human in England and Wales:
a comparison of data for 1994 and 1996. Microb Drug Resist 1997;3:263-6.
- Sramova H, Karpiskova R, Dedicova D, Sisak F, Rychlik I. Properties of Salmonella isolates in the Czech Republic. Epidemiol Mikrobiol Immunol
1999;48:111-6.
- Cherian BP, Singh N, Charles W, Prabhakar P. Extended-spectrum
beta-lactamase-producing Salmonella enteritidis in Trinidad and Tobago. Emerg
Infect Dis 1999;5:181-2.
- Blahova J, Lesicka-Hupkova M, Kralikova K, Krcmerry V, Krcmeryova T, Kubonova K.
Further occurrence of
extended-spectrum-beta-lactamase-producing Salmonella enteritidis. J Chemother 1998;10:291-4.
- Gaillot O, Clement C, Simonet M, Philippon A. Novel transferable
beta-lactam resistance with cephalosporinase characteristics in Salmonella
enteritidis. J Antimicrob Chemother 1997;39:85-7.
- Stokes H, Hall RA. A novel family of potential mobile DNA elements encoding site-specific gene integration functions:
integrons. Mol Microbiol
1989;3:1669-83.
- Rankin SC, Coyne MJ. Multiple antibiotic resistance in
Salmonella enterica serotype enteritidis. Lancet 1998;351:1740.
|